Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AREVA Research Institute is a biotechnology organization focused on the advanced study and therapeutic application of extracellular vesicles (EVs), specifically exosomes. The institute specializes in the isolation, characterization, and engineering of these vesicles to serve as next-generation drug delivery vehicles and regenerative medicine agents. By leveraging the natural signaling properties of EVs, AREVA aims to develop targeted therapies for a variety of complex diseases. Their research encompasses both the diagnostic potential of circulating vesicles and their use as biocompatible carriers for nucleic acids and small molecules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evacuation (AREVA) Research Institute.